Clinical Medicine
关注临床医学
影响因子已更新Taylor & Francis 旗下的医学与健康期领域拥有近400本相关期刊，涵盖免疫学、肿瘤医学、药学、神经学、生物学、全科医学、医学教育学等多个领域，关注基础、转化和临床的各个阶段优质研究成果。其中，超过100本期刊致力于发表临床医学实践中的创新发现、实战经验、深度理论探索和典型病例解析等内容，95%已获得影响因子！超70%已被SCI（科学引文索引）或SSCI（社会科学引文索引）权威收录!
重点学科 & 期刊列表
Journal of Hepatocellular Carcinoma
Impact Factor: 4.1 (2022)
Q2
Publishes open access research on hepatocellular carcinoma, focusing on signaling pathways, tumor classification, radiology, drug treatment and epidemiology.
International Journal of Hyperthermia
Impact Factor: 3.1 (2022)
Q2
Publishes articles on various aspects of thermal energy and thermal therapy in clinical, biological or engineering studies involving human or animals.
OncoTargets and Therapy
Impact Factor: 4.0 (2022)
Q2
Publishes open access molecular research on all types of cancer, including therapeutic targets and regimens, diagnosis, pathology, and novel treatments.
Cancer Investigation
Impact Factor: 2.4 (2022)
Publishes original papers, essays, reports on new technologies, and reviews in the fields of translational and clinical oncology.It
offers accelerated publication.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| Journal of Hepatocellular Carcinoma | 4.1 | Q2 | / |
| OncoTargets and Therapy | 4.0 | Q2 | 9.2 |
| Lung Cancer: Targets and Therapy | 3.6 | / | 7.8 |
| Cancer Management and Research | 3.3 | Q3 | 6.9 |
| International Journal of Hyperthermia | 3.1 | Q2 | 6.2 |
| Blood and Lymphatic Cancer: Targets and Therapy | 2.8 | / | / |
| Breast Cancer: Targets and Therapy | 2.6 | Q3 | 6.7 |
| Cancer Investigation | 2.4 | Q4 | 3.4 |
| Journal of Chemotherapy | 1.8 | Q4 | 3.6 |
| Pediatric Hematology and Oncology | 1.7 | Q4 | 2.7 |
Dialogues in Clinical Neuroscience
Impact Factor: 8.3 (2022)
Q1
Open Access journal
publishing at the interface between clinical neuropsychiatry and the
neurosciences focussing on relevant clinical, biological, and therapeutic
aspects.
Nature and Science of Sleep
Impact Factor: 3.4 (2022)
Q2
Publishes open access research on the neurophysiology and functions of sleep, the genetics of sleep, biological rhythms, dreaming, sleep disorders and therapy.
Expert Review of Neurotherapeutics
Impact Factor: 4.3 (2022)
Q2
A MEDLINE-indexed journal providing expert commentary on the use of drugs and medicines in clinical neurology and neuropsychiatry. It offers accelerated publication.
Behavioral Sleep Medicine
Impact Factor: 3.1 (2022)
Focuses on sleep disorders, sleep-related symptoms, insomnia and associated behavioural, cognitive, emotional, physiological and mental health problems.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| Dialogues in Clinical Neuroscience | 8.3 | Q1 | 13.4 |
| Expert Review of Neurotherapeutics | 4.3 | Q2 | 7.1 |
| Nature and Science of Sleep | 3.4 | Q2 | 3.8 |
| Neuropsychiatric Disease and Treatment | 3.2 | Q2 | 5.1 |
| Behavioral Sleep Medicine | 3.1 | Q3 | 7.2 |
| Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | 2.8 | Q3 | 5.5 |
| Journal of Pain Research | 2.7 | Q3 | 4.8 |
| Topics in Stroke Rehabilitation | 2.2 | Q2 | 4.5 |
| Brain Injury | 1.9 | Q2 | 3.4 |
| Neurological Research | 1.9 | Q4 | 4.0 |
| The Journal of Spinal Cord Medicine | 1.7 | Q4 | 3.9 |
| CRANIO® | 1.6 | Q4 | 3.2 |
| Research and Practice in Intellectual and Developmental Disabilities | 1.4 | / | 3.0 |
| Developmental Neurorehabilitation | 1.3 | Q4 | 3.2 |
| British Journal of Neurosurgery | 1.1 | Q4 | 2.5 |
| Neuro-Ophthalmology | 0.8 | / | 1.5 |
| The Neurodiagnostic Journal | / | / | 0.8 |
Climacteric
Impact Factor: 2.8 (2022)
Q2
Climacteric publishes research into menopause, climacteric and mid-life health, including counselling and education of peri- and post- menopausal women.
Journal of Psychosomatic Obstetrics & Gynecology
Impact Factor: 3.1 (2022)
Q2
Focuses on psychosomatic and psychosocial aspects of women’s health in various disciplines such as gynecology, obstetrics, nursing, psychiatry and psychology.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| Climacteric | 2.8 | Q2 | 5.8 |
| Gynecological Endocrinology | 2.0 | Q3 | 4.2 |
| Human Fertility | 1.9 | Q4 | 4.1 |
| The Journal of Maternal-Fetal & Neonatal Medicine | 1.8 | Q4 | 3.9 |
| The European Journal of Contraception & Reproductive Health Care | 1.7 | Q4 | 3.0 |
| Hypertension in Pregnancy | 1.5 | Q4 | 3.6 |
| Journal of Obstetrics and Gynaecology | 1.3 | Q4 | 1.8 |
International Journal of Audiology
Impact Factor: 2.7 (2022)
Q1
An international journal publishing research into audiology and hearing sciences including psychoacoustics, hearing impairment and rehabilitation devices.
Clinical, Cosmetic and Investigational Dentistry
Impact Factor: 1.8 (2022)
Publishes open access research on dentistry, focusing on cosmetic intervention, including novel materials, techniques and devices, surgery, and orthodontics.
Clinical and Experimental Optometry
Impact Factor: 1.9 (2022)
Publishes research in optometry and vision science, including clinical refraction, spectacle and contact lenses, eye disease, and ocular therapeutics.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| International Journal of Audiology | 2.7 | Q1 | 4.4 |
| Clinical Ophthalmology | 2.2 | / | 3.5 |
| Clinical and Experimental Optometry | 1.9 | Q3 | 4.5 |
| Clinical, Cosmetic and Investigational Dentistry | 1.8 | / | 3.3 |
| International Journal of Speech-Language Pathology | 1.8 | Q2 | 3.7 |
| Clinical Optometry | 1.7 | / | 3.2 |
| Seminars in Ophthalmology | 1.7 | Q4 | 2.8 |
| Cochlear Implants International | 1.6 | / | 2.6 |
| Speech, Language and Hearing | 1.5 | / | 2.0 |
| Acta Oto-Laryngologica | 1.4 | Q4 | 2.4 |
| Ophthalmic Genetics | 1.2 | Q4 | 1.9 |
| Orbit | 1.1 | / | 2.1 |
| Strabismus | 0.9 | / | 1.8 |
| Clinical and Investigative Orthodontics | 0.4 | / | 0.5 |
| Acta Oto-Laryngologica Case Reports | 0.1 | / | / |
Psychology Research and Behavior Management
Impact Factor: 4.3 (2022)
Q1
Publishes open access research on behavioral, cognitive and social neuroscience, psychophysiology, behavior management and learning.
International Journal of Psychiatry in Clinical Practice
Impact Factor: 3.0 (2022)
Focuses on mental health, neuropsychopharmacology, neuropsychiatry, clinical neurophysiology, psychotherapy, addiction, depression, anxiety and schizophrenia.
Psychology, Health & Medicine
Impact Factor: 3.8 (2022)
Q2
Publishes research on human factors in health and illness, biopsychosocial approaches to medical care and management, and psychology and health in practice.
Journal of Psychoactive Drugs
Impact Factor: 2.8 (2022)
Q2
Focuses on drug abuse, dependence, addiction, rehabilitation and research, hallucinogens, psychotherapy and counseling of individuals and families.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| International Journal of Transgender Health | 4.6 | Q1 | 8.3 |
| Psychology Research and Behavior Management | 4.3 | Q1 | 4.7 |
| Psychology, Health & Medicine | 3.8 | Q2 | 5.5 |
| Journal of Sex Research | 3.6 | Q1 | 7.2 |
| Journal of Psychosomatic Obstetrics & Gynecology | 3.1 | Q2 | 5.6 |
| The World Journal of Biological Psychiatry | 3.1 | Q3 | 6.4 |
| International Journal of Psychiatry in Clinical Practice | 3.0 | Q3 | 4.4 |
| Journal of Psychoactive Drugs | 2.8 | Q2 | 5.7 |
| The American Journal of Drug and Alcohol Abuse | 2.7 | Q3 | 6.2 |
| Behavioral Medicine | 2.3 | Q2 | 7.0 |
| Journal of Addictive Diseases | 2.3 | Q3 | 2.9 |
| Journal of Dual Diagnosis | 2.2 | Q3 | 3.7 |
| Issues in Mental Health Nursing | 2.1 | Q2 | 2.9 |
| Substance Use & Misuse | 2.0 | Q3 | 3.2 |
| International Journal of Sexual Health | 2.0 | Q2 | 2.8 |
| Nordic Journal of Psychiatry | 1.8 | Q4 | 3.7 |
| Children’S Health Care | 0.9 | Q4 | 1.8 |
| Journal of Occupational Therapy, Schools & Early Intervention | 0.7 | / | 1.2 |
Critical Reviews in Clinical Laboratory Sciences
Impact Factor: 10.0 (2022)
Q1
Publishes reviews on clinical laboratory aspects of biochemistry, microbiology, pathology, transfusion medicine, genetics, immunology and molecular diagnostics.
Biomarkers
Impact Factor: 2.6 (2022)
Accepts studies on humans/animals on biomarkers of disease, exposure, response and susceptibility, focusing on relationships between markers and effects. It
offers accelerated publication.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| Critical Reviews in Clinical Laboratory Sciences | 10.0 | Q1 | 15.7 |
| Expert Opinion on Biological Therapy | 4.6 | Q2 | 8.5 |
| Biomarkers | 2.6 | Q3 | 4.5 |
| Scandinavian Journal of Clinical and Laboratory Investigation | 2.1 | Q4 | 3.5 |
| Growth Factors | 1.8 | Q4 | 2.9 |
| Experimental Lung Research | 1.7 | Q4 | 3.4 |
| Hemoglobin | 1.0 | Q4 | 1.4 |
Expert Review of Clinical Immunology
Impact Factor: 4.4 (2022)
Q2
A MEDLINE-indexed, peer-reviewed journal providing the latest research on the performance of new therapeutic and diagnostic modalities in clinical immunology. This journal offers accelerated publication.
Clinical Epidemiology
Impact Factor: 3.9 (2022)
Q2
Publishes open access research on epidemiology and clinical care, including electronic records, data-gathering, diagnostic procedures and predictive markers.
Immunological Medicine
Impact Factor: 4.4 (2022)
Advances in the field of clinical immunology including autoimmune and infectious diseases that require immunological approaches from various medical fields.
The European Journal of General Practice
Impact Factor: 3.4 (2022)
Q1
Publishes open access research on medical decision-making, healthcare delivery, medical education, and research methodology for primary care practice.
医学与健康及其他各学科高水平国际期刊，请访问 Taylor & Francis Group 旗下学术期刊网站， 欢迎相关学科研究人员向您青睐的杂志投稿。
期刊网站：www.tandfonline.com
选择加速出版
如果时间对于您至关重要，我们部分医学与健康及药学期刊提供加速出版服务。我们将通过投入额外的资源来监控和管理同行评审流程，满足紧迫的周转时间要求，帮助您快速发表研究成果。
为期刊、图书作者提供的实用指南
在您准备撰写一篇国际学术论文时，一个为您提供必要指导和资源实用网站可以为您解答许多疑问！从选刊、写作、投稿、同行评审、出版等各个方面给予详细的指导，写作投稿前的必看网站！
拥抱开放科学
开放获取对于作者、读者而言极具价值，开放科学让研究在更广泛的维度得到参考和使用，提升研究可见度和影响力，造福社会。您是否考虑发表开放获取文章？点击了解开放获取出版更多信息
联系我们
Taylor & Francis Group拥有220多年的历史，是全球领先的学术出版集团，业务包括学术期刊、图书、电子书、教科书和参考书。以高质量的学术内容和服务水平，每年出版期刊2600余种，新书7000余册，累计图书出版量15万余册。旗下包括Routledge, CRC Press, Taylor & Francis等品牌，实现全学科均衡覆盖。我们整合数据、资源和技术优势，愿为中国研究人员和中国开放科学的发展提升，贡献更多的智慧和力量。